These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 11698463

  • 1. The development of a Th1-type response and resistance to Leishmania major infection in the absence of CD40-CD40L costimulation.
    Padigel UM, Perrin PJ, Farrell JP.
    J Immunol; 2001 Nov 15; 167(10):5874-9. PubMed ID: 11698463
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. TRANCE-RANK costimulation is required for IL-12 production and the initiation of a Th1-type response to Leishmania major infection in CD40L-deficient mice.
    Padigel UM, Kim N, Choi Y, Farrell JP.
    J Immunol; 2003 Nov 15; 171(10):5437-41. PubMed ID: 14607948
    [Abstract] [Full Text] [Related]

  • 5. CD28 costimulation and parasite dose combine to influence the susceptibility of BALB/c mice to infection with Leishmania major.
    Compton HL, Farrell JP.
    J Immunol; 2002 Feb 01; 168(3):1302-8. PubMed ID: 11801669
    [Abstract] [Full Text] [Related]

  • 6. Disruption of CD40/CD40L interaction influences the course of Cryptococcus neoformans infection.
    Pietrella D, Lupo P, Perito S, Mosci P, Bistoni F, Vecchiarelli A.
    FEMS Immunol Med Microbiol; 2004 Jan 15; 40(1):63-70. PubMed ID: 14734188
    [Abstract] [Full Text] [Related]

  • 7. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb.
    Ferlin WG, von der Weid T, Cottrez F, Ferrick DA, Coffman RL, Howard MC.
    Eur J Immunol; 1998 Feb 15; 28(2):525-31. PubMed ID: 9521062
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
    Hayakawa Y, Takeda K, Yagita H, Van Kaer L, Saiki I, Okumura K.
    J Immunol; 2001 May 15; 166(10):6012-8. PubMed ID: 11342617
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Contribution of interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 ligand pathways to the development of a pathological T-cell response in IL-10-deficient mice.
    Wille U, Villegas EN, Craig L, Peach R, Hunter CA.
    Infect Immun; 2002 Dec 15; 70(12):6940-7. PubMed ID: 12438373
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with histoplasma capsulatum.
    Zhou P, Seder RA.
    J Exp Med; 1998 Apr 20; 187(8):1315-24. PubMed ID: 9547342
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression and contribution of B7-1 (CD80) and B7-2 (CD86) in the early immune response to Leishmania major infection.
    Elloso MM, Scott P.
    J Immunol; 1999 Jun 01; 162(11):6708-15. PubMed ID: 10352289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.